Amgen (AMGN) EPS (Weighted Average and Diluted) Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
169.93% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-52.86% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-45.83% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-185.57% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
4.37% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
54.81% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
-9.62% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
9.17% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
4.37% |
| Dec 31, 2025 |
112.07% |
| Sep 30, 2025 |
13.60% |
| Jun 30, 2025 |
92.03% |
| Mar 31, 2025 |
1,623.81% |
| Dec 31, 2024 |
-18.88% |
| Sep 30, 2024 |
62.11% |
| Jun 30, 2024 |
-46.30% |
| Mar 31, 2024 |
-103.98% |
| Dec 31, 2023 |
-52.33% |
| Sep 30, 2023 |
-19.10% |
| Jun 30, 2023 |
4.90% |
| Mar 31, 2023 |
97.01% |
| Dec 31, 2022 |
-10.45% |
| Sep 30, 2022 |
20.24% |
| Jun 30, 2022 |
202.47% |
| Mar 31, 2022 |
-5.30% |
| Dec 31, 2021 |
21.38% |
| Sep 30, 2021 |
-3.50% |
| Jun 30, 2021 |
-73.44% |
| Mar 31, 2021 |
-7.82% |
| Dec 31, 2020 |
-3.16% |
| Sep 30, 2020 |
4.89% |
| Jun 30, 2020 |
-14.57% |
| Mar 31, 2020 |
-3.46% |
| Dec 31, 2019 |
-5.32% |
| Sep 30, 2019 |
14.34% |
| Jun 30, 2019 |
2.59% |
| Mar 31, 2019 |
-2.15% |
| Dec 31, 2018 |
151.10% |
| Sep 30, 2018 |
3.62% |
| Jun 30, 2018 |
19.59% |
| Mar 31, 2018 |
16.49% |
| Dec 31, 2017 |
-327.41% |
| Sep 30, 2017 |
2.99% |
| Jun 30, 2017 |
17.81% |
| Mar 31, 2017 |
11.60% |
| Dec 31, 2016 |
9.28% |
| Sep 30, 2016 |
9.84% |
| Jun 30, 2016 |
14.88% |
| Mar 31, 2016 |
18.48% |
| Dec 31, 2015 |
41.07% |
| Sep 30, 2015 |
51.55% |
| Jun 30, 2015 |
6.97% |
| Mar 31, 2015 |
50.71% |
| Dec 31, 2014 |
26.32% |
| Sep 30, 2014 |
-10.06% |
| Jun 30, 2014 |
21.82% |
| Mar 31, 2014 |
-25.53% |
| Dec 31, 2013 |
31.68% |
| Sep 30, 2013 |
26.95% |
| Jun 30, 2013 |
2.48% |
| Mar 31, 2013 |
27.03% |
| Dec 31, 2012 |
-6.48% |
| Sep 30, 2012 |
182.00% |
| Jun 30, 2012 |
28.80% |
| Mar 31, 2012 |
23.33% |
| Dec 31, 2011 |
0.00% |
| Sep 30, 2011 |
-60.94% |
| Jun 30, 2011 |
0.00% |
| Mar 31, 2011 |
1.69% |
| Dec 31, 2010 |
17.39% |
| Sep 30, 2010 |
-5.88% |
| Jun 30, 2010 |
0.00% |
| Mar 31, 2010 |
20.41% |
